The ability to model the interactions between average daily glucose concentrations as measured by CGM and insulin dose could be very useful because it could guide clinicians in titrating insulin to maximize the benefit of dapagliflozin in patients with T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.